Objectives: The objective of this study was to investigate the association between SLE and Bipolar Disorder (BD) using big data analysis methods. Methods: Patients with SLE were compared with age-and sex-matched controls regarding the proportion of BD in a cross-sectional study. Chi-square and t-tests were used for univariate analysis and a logistic regression model was used for multivariate analysis, adjusting for confounders. The study was performed utilizing the chronic disease registry of Clalit Health Services medical database. Results: The study included 5,018 SLE patients and 25,090 matched controls. BD was found in a higher proportion among SLE patients compared to controls (0.62% vs. 0.26%, respectively, p<0.001). BD patients had a greater proportion of smokers compared to non-BD patients (62.5% vs 23.5%, respectively, p<0.001). In a multivariate analysis, smoking and SLE were both found to be significantly associated with BD. Background: As well as other systemic inflammatory diseases with joint compromise, there is an interest to identify the presence of synovitis in systemic lupus erythematosus (SLE) patients, in every follow up consultation. In SLE, the research about subclinical synovitis (that, which is clinically unnoticed but demonstrable by means of image studies) is quiet limited. The majority of studies focused on the use of ultrasound (US) assessment of patients with SLE included non selected patients so many of them counted with patients with chronic synovitis or even deformities. Due to that their results are difficult to compare and the real prevalence of subclinical synovitis is still unknown. Objectives: To determine the prevalence of synovitis in a selected cohort of patients without clinical evidence of arthritis or synovitis. Methods: We performed a prospective study on 96 SLE patients grouped as follows: Group 0 (20) without no historical or present joint symptoms, Group 1 (34) with intermittent joint pain and Group 2 (42) with intermittent arthritis without deformities or erosions. A systematic US study of the carpal, 2nd and 3rd MCP joint of the non dominant hand were performed to all patients. US findings were expressed according to the nomenclature EULAR recommendations for synovitis, power Doppler signal and composite synovitis index. Results: Six patients from group 0 showed any grade of synovitis (30%), 13 from group I (38.2%) and 18 from group II (42.8%). From the whole group of subjects, those with at least a synovitis finding was 37 (38.5%). Into the 2nd MCP joint, 4 patients (20%) from group 0 showed any grade of synovitis, one of them (5%) with power Doppler (PD) signal. The composite index of synovitis and PD signal (CSI) was 0.3 DE 0.36. In group 1, 9 patients (26.5%) showed any grade of synovitis, 4 of them also showed PD signal (11.8%). The CSI for this group was 0.44 DE 0.48. In group 2, 15 patients (14.3%) showed any grade of synovitis and 6 of them also showed PD signal (14.3%). The CSI for this group was 0.59 DE 0.55. Globally, we detected synovitis in 28/96 patients (29.2%) and PD signal in 11 (11.5%). Into the 3rd MCP joint, 5 patients (25%) from group 0 showed any grade of synovitis, one of them (5%) also had PD signal. The CSI for this group was 0.3 DE 0.36. In group 1, 8 patients had synovitis (23.5%), 3 of them also showed PD signal (8.8%). The CSI for this group was 0.38 De 0.46. In group 2, 15 patients showed any kind of synovitis (35.7%), 4 of them with PD signal (9.5%). CSI index for this group was 0.57 DE 0.61. Globally there where 27/96 patients with synovitis (28.1%) and 8 with PD signal. Into the carpal dorsal aspect, 5 patients of group 0 has synovitis (25%) and 3 PD signal (15% Background: Pregnancies in women with SLE resulted in an increase of adverse pregnancy outcomes (APOs). The predictive value of fetal umbilical artery Doppler examinations for APOs has been reported, while not widely be assessed in SLE pregnant women. Objectives: To ascertain the predictive value of fetal umbilical artery Doppler for fetal APOs in SLE pregnancies. Methods: A fetal Doppler ultrasound examination was performed on all fetuses during the third trimester (28∼36 weeks of gestation) and the term pregnancy (37∼42 weeks of gestation). The Doppler flow parameters of umbilical arteries were recorded, including pulsatility parameter (PI), resistance index (RI), the peak value of umbilical arteries at end-systole (Vmax, also abbreviate as S) and the peak value of umbilical arteries at end-diastole (Vmin, also abbreviate as D). The value of S/D was automatically calculated. Clinical data and pregnancy outcomes were also analyzed retrospectively. Results: In total, 109 cases of pregnant SLE women performed fetal umbilical artery Doppler at the third trimester and 82 at the term pregnancy. Among the 109 cases, 65 resulted in one or more APOs, including 45 with premature delivery, 23 with intrauterine growth restriction (IUGR), 16 with fetal distress, 8 with neonatal lupus (NLE) and 3 with congenital malformation. Fetus with APOs had higher S/D values compared with fetus without APOs (2.9±0.9 VS. 2.4±0.5, P=0.001). In addition, other Doppler indexes did not differ significantly across groups. The area under the receiver operating characteristic curve was 0.7 (P=0.003) for S/D values, with the optimal cutoff of 2.8. At this cutoff, sensitivity (46.2%) and specificity (90.9%) had the best combination, whereas the positive and negative predictive values were 83.3% and 52.1%, respectively. Among the 82 cases with term pregnancy, 23 resulted in APOs, including 11 with IUGR, 15 with fetal distress, 4 with NLE and 1 with congenital malformation. All of the Doppler indexes (S/D, PI, RI, Vmax and Vmin) in fetus with APOs were higher than those without APOs, but no statistical significance were found between the 2 groups. Conclusions: Umbilical artery Doppler was a good monitor method for APOs in the third trimester. S/D values were sensitive and specific predictors for APOs in pregnancies complicated by SLE. Women with more than 2.8 S/D could start strict monitoring to rapidly identify and treat obstetric complications. developed as a flare of systemic lupus erythematosus (SLE) after treating the prior non-renal SLE conditions successfully (delayed, D-LN) and LN manifesting at the time of SLE onset (early, E-LN). 1) More frequent flares and higher serum titers of anti-dsDNA antibody during the LN flares were observed in D-LN than E-LN groups, suggesting that D-LN may reflect intractable SLE conditions. However, we had not analyzed whether there is a difference in the response to treatment between the two groups. Objectives: This study investigated possible differences in the response to induction therapy between E-LN and D-LN. Methods: We retrospectively examined 95 LN (48 E-LN, 47 D-LN) patients who attended our hospital between January 1991 and May 2016. All of them were diagnosed with SLE according to the American College of Rheumatology criteria and were shown to have LN on renal biopsy. First, we compared the clinical features of E-LN and D-LN, such as sex, age at SLE and LN onset, urinary protein, serum creatinine, serum anti-dsDNA titer, serum C3, prevalence of serum anti-Sm, renal biopsy histological types and induction therapy options at LN onset. Then we compared the response to therapy at 24 weeks for LN onset and flares between the two groups. The response to treatment was classified into complete response [CR; urine protein to creatinine ratio <50 mg/mmol and normal or nearnormal (within 10%)GFR], partial response [PR; ≥50% reduction in proteinuria to sub-nephrotic levels and (near-) normal GFR], and insufficient response [IR; anything else]. We analyzed the data using chi-square test, Fisher's exact test and the Mann-Whitney U-test. We further evaluated predictors of treatment response at LN onset using univariate and forward stepwise multivariate Cox regression analysis. 
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1) More frequent flares and higher serum titers of anti-dsDNA antibody during the LN flares were observed in D-LN than E-LN groups, suggesting that D-LN may reflect intractable SLE conditions. However, we had not analyzed whether there is a difference in the response to treatment between the two groups. Objectives: This study investigated possible differences in the response to induction therapy between E-LN and D-LN. Methods: We retrospectively examined 95 LN (48 E-LN, 47 D-LN) patients who attended our hospital between January 1991 and May 2016. All of them were diagnosed with SLE according to the American College of Rheumatology criteria and were shown to have LN on renal biopsy. First, we compared the clinical features of E-LN and D-LN, such as sex, age at SLE and LN onset, urinary protein, serum creatinine, serum anti-dsDNA titer, serum C3, prevalence of serum anti-Sm, renal biopsy histological types and induction therapy options at LN onset. Then we compared the response to therapy at 24 weeks for LN onset and flares between the two groups. The response to treatment was classified into complete response [CR; urine protein to creatinine ratio <50 mg/mmol and normal or nearnormal (within 10%)GFR], partial response [PR; ≥50% reduction in proteinuria to sub-nephrotic levels and (near-) normal GFR], and insufficient response [IR; anything else]. We analyzed the data using chi-square test, Fisher's exact test and the Mann-Whitney U-test. We further evaluated predictors of treatment response at LN onset using univariate and forward stepwise multivariate Cox regression analysis. Methods: A sensitive search, on behalf of the EULAR study group on microcirculation in Rheumatic Diseases, was developed in Web Of Science, PubMed and Embase to identify all original research studies in which SLE patients had capillaroscopy. Two reviewers identified titles, abstracts and full texts. Exclusion criteria were: ACR criteria for SLE were not met, less than 5 patients were included in the study, there was no information on capillaroscopy in SLE, no original research or non-English language. All included articles underwent quality appraisal. Results were summarised according to density, dimensions, morphology, haemorrhages, semi quantitative assessment, qualitative assessment (see table) and correlation of capillaroscopic changes with clinical and laboratory parameters. Results: From 172 articles captured, 36 articles were included in this review.
The following capillaroscopic parameters were significantly more prevalent in SLE patients compared to healthy controls (see table) : tortuous capillaries, abnormal morphology, haemorrhages, nailfold capillaroscopic score, "non-specific patterns" and "scleroderma like pattern". Hairpin shaped capillaries were significantly more prevalent in healthy controls compared to SLE patients. For clinical and laboratory parameters, Raynaud's phenomenon (RP), gangrene and 24 hours proteinuria were significantly correlated with capillaroscopic changes. 
Conclusions

